Levin Capital Strategies’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,250
| Closed | -$49K | – | 202 |
|
|
2019
Q4 | $49K | Buy |
+1,250
| New | +$49K | ﹤0.01% | 204 |
|
|
2019
Q2 | – | Sell |
-2,500
| Closed | -$112K | – | 215 |
|
|
2019
Q1 | $112K | Buy |
+2,500
| New | +$112K | 0.01% | 181 |
|
|
2018
Q4 | – | Sell |
-1,667
| Closed | -$111K | – | 276 |
|
|
2018
Q3 | $111K | Sell |
1,667
-1,416
| -46% | -$94.3K | ﹤0.01% | 257 |
|
|
2018
Q2 | $145K | Buy |
3,083
+1,375
| +81% | +$64.7K | ﹤0.01% | 264 |
|
|
2018
Q1 | $97K | Buy |
+1,708
| New | +$97K | ﹤0.01% | 290 |
|
|
2017
Q4 | – | Sell |
-4,425
| Closed | -$337K | – | 333 |
|
|
2017
Q3 | $337K | Buy |
4,425
+2,467
| +126% | +$188K | 0.01% | 245 |
|
|
2017
Q2 | $184K | Buy |
1,958
+708
| +57% | +$66.5K | ﹤0.01% | 284 |
|
|
2017
Q1 | $99K | Buy |
+1,250
| New | +$99K | ﹤0.01% | 287 |
|